alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7329 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7329

 To amend title 5, United States Code, to establish Election Day as a 
             legal public holiday, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 13, 2024

Ms. Eshoo (for herself, Mrs. Watson Coleman, Ms. Norton, Mr. Goldman of 
     New York, Ms. Williams of Georgia, Mr. Schiff, Mr. Meeks, Ms. 
   Velazquez, Ms. Lee of California, Mr. Phillips, Mr. Moulton, Mr. 
  Thompson of Mississippi, Mr. Johnson of Georgia, Ms. Clarke of New 
 York, Mr. Garamendi, Mr. Ruppersberger, Mr. Carson, Mr. Grijalva, Mr. 
  Casten, Mr. Lieu, Mr. Espaillat, and Mr. Blumenauer) introduced the 
 following bill; which was referred to the Committee on Oversight and 
                             Accountability

_______________________________________________________________________

                                 A BILL

 
 To amend title 5, United States Code, to establish Election Day as a 
             legal public holiday, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Election Day Holiday Act of 2024''.

SEC. 2. ELECTION DAY AS A LEGAL PUBLIC HOLIDAY.

    Section 6103(a) of title 5, United States Code, is amended by 
inserting after the item relating to Columbus Day the following:
            ``Election Day.''.
                                 <all>
```
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               APR-03-1999
<CASH>                                           6,351
<SECURITIES>                                         0
<RECEIVABLES>                                   79,452
<ALLOWANCES>                                     3,036
<INVENTORY>                                     68,027
<CURRENT-ASSETS>                               180,190
<PP&E>                                         136,073
<DEPRECIATION>                                  70,202
<TOTAL-ASSETS>                                 286,238
<CURRENT-LIABILITIES>                           55,437
<BONDS>                                         66,320
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           113
<OTHER-SE>                                     161,575
<TOTAL-LIABILITY-AND-EQUITY>                   286,238
<SALES>                                         70,311
<TOTAL-REVENUES>                                70,311
<CGS>                                           35,940
<TOTAL-COSTS>                                   35,940
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                   141
<INTEREST-EXPENSE>                               1,232
<INCOME-PRETAX>                                  2,767
<INCOME-TAX>                                       985
<INCOME-CONTINUING>                              1,782
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,782
<EPS-PRIMARY>                                     0.19
<EPS-DILUTED>                                     0.19
        

</TABLE>
### Ground-water in the Teresina-Campo Maior area, Piaui, Brazil

By: Harry G. RodisEdison F. Suszczynski

                            https://doi.org/10.3133/wsp1663G

#### Links

-                                                                                                                             Document:                                                                                                                                                                                                                                                  **Report**                                                                                                     (pdf)                                                                                                                                     
- Plate:  **Plate 1**                            (pdf)
- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.
Editorial Note on Part 312
Editorial Note: Nomenclature changes to part 312 appear at 69 FR 13717, Mar. 24, 2004.

§ 312.130 Availability for public disclosure of data and information in an IND. ( a ) The existence of an investigational new drug application will not be disclosed by FDA unless it has previously been publicly disclosed or acknowledged.
( b ) The availability for public disclosure of all data and information in an investigational new drug application for a new drug will be handled in accordance with the provisions established in § 314.430 for the confidentiality of data and information in applications submitted in part 314. The availability for public disclosure of all data and information in an investigational new drug application for a biological product will be governed by the provisions of §§ 601.50 and 601.51.
( c ) Notwithstanding the provisions of § 314.430, FDA shall disclose upon request to an individual to whom an investigational new drug has been given a copy of any IND safety report relating to the use in the individual.
( d ) The availability of information required to be publicly disclosed for investigations involving an exception from informed consent under § 50.24 of this chapter will be handled as follows: Persons wishing to request the publicly disclosable information in the IND that was required to be filed in Docket Number 95S-0158 in the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, shall submit a request under the Freedom of Information Act.
[52 FR 8831, Mar. 19, 1987. Redesignated at 53 FR 41523, Oct. 21, 1988, as amended at 61 FR 51530, Oct. 2, 1996; 64 FR 401, Jan. 5, 1999; 68 FR 24879, May 9, 2003; 88 FR 45065, July 14, 2023]
NOTE: This disposition is nonprecedential.

 

United States Court of Appeals 

for the Federal Circuit ______________________ 

FRANK CALAPRISTI, AND OTHER SIMILARLY 

SITUATED PERSONS,

Plaintiff-Appellant

v.

UNITED STATES,

Defendant-Appellee

______________________ 

2022-1080

______________________ 

Appeal from the United States Court of Federal Claims 

in No. 1:18-cv-00612-TMD, Judge Thompson M. Dietz.

______________________ 

JUDGMENT

______________________ 

DOUGLAS E. MCKINLEY, JR., Law Office of Douglas E. 

McKinley, Jr., Kennewick, WA, argued for plaintiff-appellant. 

 ALBERT S. IAROSSI, Commercial Litigation Branch, 

Civil Division, United States Department of Justice, Washington, DC, argued for defendant-appellee. Also represented by BRIAN M. BOYNTON, STEVEN JOHN GILLINGHAM,

PATRICIA M. MCCARTHY. 

 ______________________ 

Case: 22-1080 Document: 34 Page: 1 Filed: 11/03/2022
THIS CAUSE having been heard and considered, it is 

ORDERED and ADJUDGED: 

 PER CURIAM (MOORE, Chief Judge, LOURIE and 

PROST, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

 

 ENTERED BY ORDER OF THE COURT 

 

November 3, 2022 

Date

/s/ Peter R. Marksteiner

Peter R. Marksteiner

Clerk of Court

Case: 22-1080 Document: 34 Page: 2 Filed: 11/03/2022
**Exhibit 32**

**CERTIFICATION**

 

The certifications set forth below are herebysubmitted to the Securities and Exchange Commission pursuant to, and solely forthe purpose of complying with, Section 1350 of Chapter 63 of Title 18 of theUnited States Code in connection with the filing on the date hereof with theSecurities and Exchange Commission of the Quarterly Report on Form 10-Q of theCompany for the quarter ended September 30, 2003.

 

Each of the undersigned hereby certifiesin his capacity as an officer of Citizens Bancshares Corporation andsubsidiaries (the “Company”) that the Quarterly Report of the Company on Form10-Q for the period ended September 30, 2003 fully complies with therequirements of Section 13(a) of the Securities Exchange Act of 1934 and thatthe information contained in such report fairly presents, in all materialrespects, the financial condition of the Company at the end of such period andthe results of operations of the Company for such period.

 

**SIGNATURES**

 

In accordance with the requirements of the Exchange Act, the registrantcaused this report to be signed on its behalf by the undersigned, thereuntoduly authorized.

 

**CITIZENS BANCSHARES CORPORATION**

 

 
| Date:  | April 12, 2004 | By:    | /s/ James E. Young                    |   |
|--------|----------------|--------|---------------------------------------|--------|
|   |           |   | James E. Young                        |
|   |           |   | President and Chief Executive Officer |
|   |           |   |                                  |
| Date:  | April 12, 2004 | By:    | /s/ Willard C. Lewis                  |   |
|   |           |   | Willard C. Lewis                      |
|   |           |   | Senior Executive Vice President and   |
|   |           |   | Chief Operating Officer               |
|   |           |   |                                  |
| Date:  | April 12, 2004 | By:    | /s/ Samuel J. Cox                     |   |
|   |           |   | Samuel J. Cox                         |
|   |           |   | Senior Vice President and             |
|   |           |   | Chief Financial Officer               |
|        |                |        |                                       |        |  |

 

1

----
[No. 39294-8-I.

Division One.

January 26, 1998.]

#### The State of Washington, *Respondent,*v. Damon Hampton, *Appellant.*

Appeal from a judgment of the Superior Court for Snohomish County, No. 96-1-00784-1, Paul D. Hansen, J., entered August 23, 1996. *Affirmed*by unpublished per curiam opinion.
#### § 500.30 Gentian violet for animal drug use.

The Food and Drug Administration (FDA) has determined that gentian violet is not generally recognized as safe and effective for any veterinary drug use in food animals and is a new animal drug subject to section 512 of the Federal Food, Drug, and Cosmetic Act. FDA has determined that gentian violet is not exempted from new animal drug status under the “grandfather” provisions of the Drug Amendments of 1962 (21 U.S.C. 342).

[56 FR 40507, Aug. 15, 1991]
# EUR-Lex - 31993D0493 - EN

Avis juridique important

*|*

# 31993D0493

**93/493/EEC: Commission Decision of 27 July 1993 amending Decision 83/471/EEC relating to the Community Inspection Committee on the application of the classification scale for carcases of adult bovine animals **

*
Official Journal L 230 , 11/09/1993 P. 0020 - 0020 Finnish special edition: Chapter 3 Volume 52 P. 0110 Swedish special edition: Chapter 3 Volume 52 P. 0110 *

COMMISSION DECISION of 27 July 1993 amending Decision 83/471/EEC relating to the Community Inspection Committee on the application of the classification scale for carcases of adult bovine animals

(93/493/EEC)THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community,

Having regard to Council Regulation (EEC) No 1208/91 of 28 April 1981 determining the Community scale for the classification of carcases of adult bovine animals (1), as last amended by Regulation (EEC) No 1026/91 (2), and in particular Article 5 (4) thereof,

Whereas, with a view to enabling the Commission to evaluate the results of inspections, provision should be made for the Member States to inform the Commission of the action taken regarding recommendations made by the Inspection Committee and appropriately to adjust Commission Decision 83/471/EEC of 7 September 1983 relating to the Community Inspection Committee on the application of the classification scale for carcases of adult bovine animals (3), as last amended by Decision 92/429/EEC (4);

Whereas the measures provided for in this Regulation are in accordance with the opinion of the Management Committee for Beef and Veal,

HAS ADOPTED THIS DECISION:

Article 1

The following paragraph is hereby added to Article 4 of Decision 83/471/EEC:

'3. When the report referred to in paragraph 2 notes shortcomings in the various fields of activity which were the subject of verification, or makes recommendations with a view to improving operations, the Member States shall inform the Commission of all changes which are envisaged or have taken place not later than three months after the date on which the report was transmitted.'

Article 2

This Decision is addressed to the Member States.

Done at Brussels, 27 July 1993.

For the Commission

René STEICHEN

Member of the Commission

(1) OJ No L 123, 7. 5. 1981, p. 3.

(2) OJ No L 106, 26. 4. 1991, p. 2.

(3) OJ No L 259, 20. 9. 1983, p. 30.

(4) OJ No L 237, 20. 8. 1992, p. 15.
**Exhibit 32**

 

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350AS ADOPTEDPURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2003.**

 

The certifications set forth below are herebysubmitted to the Securities and Exchange Commission pursuant to, and solely forthe purpose of complying with, Section 1350 of Chapter 63 of Title 18 ofthe United States Code in connection with the filing on the date hereof withthe Securities and Exchange Commission of the Quarterly Report on Form 10-Qof the Company for the quarter ended June 30, 2005.

 

Each of the undersigned hereby certifies in his capacity as an officerof Citizens Bancshares Corporation and subsidiaries (the “Company”) that, tohis knowledge on the date of this certification, the Quarterly Report of theCompany on Form 10-Q for the period ended June 30, 2005 fullycomplies with the requirements of Section 13(a) of the SecuritiesExchange Act of 1934 and that the information contained in such report fairlypresents, in all material respects, the financial condition of the Company atthe end of such period and the results of operations of the Company for suchperiod.

 

 
| Date:  | August 12, 2005 |                                               | By:    | /s/ James E. Young |   |
|--------|----------------------|----------------------------------------------------|--------|--------------------|--------|
|   |                 | James E. Young                                     |
|   |                 | President and Chief Executive Officer              |
|   |                 |                                               |
|   |                 |                                               |   |
| Date:  | August 12, 2005 |                                               | By:    | /s/ Samuel J. Cox  |   |
|   |                 | Samuel J. Cox                                      |
|   |                 | Senior Vice President and  Chief Financial Officer |
|        |                      |                                                    |        |                    |        |  |

 

1

----
§ 226.1 Current good manufacturing practice. ( a ) The criteria in §§ 226.10 through 226.115, inclusive, shall apply in determining whether the methods used in, or the facilities and controls used for the manufacture, processing, packing, or holding of a Type A medicated article(s) conform to or are operated or administered in conformity with current good manufacturing practice to assure that a Type A medicated article(s) meets the requirements of the act as to safety, and has the identity and strength, and meets the quality and purity characteristics which it purports or is represented to possess, as required by section 501(a)(2)(B) of the act. The regulations in this part 226 permit the use of precision, automatic, mechanical, or electronic equipment in the production of a Type A medicated article(s) when adequate inspection and checking procedures or other quality control procedures are used to assure proper performance.
( b ) In addition to maintaining records and reports required in this part, Type A medicated articles requiring approved NADAs are subject to the requirements of § 514.80 of this chapter. Similarly, Type A medicated articles listed in the index are subject to the requirements of § 516.165 of this chapter.
[40 FR 14031, Mar. 27, 1975, as amended at 68 FR 15364, Mar. 31, 2003; 72 FR 69120, Dec. 6, 2007]
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM (A) FORM
10-Q FOR THE QUARTERLY PERIOD ENDED MARCH 31, 1999 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH (B) FORM 10-Q.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                           8,249
<SECURITIES>                                         0
<RECEIVABLES>                                   43,740
<ALLOWANCES>                                     4,800
<INVENTORY>                                      3,231
<CURRENT-ASSETS>                                71,135
<PP&E>                                          63,669
<DEPRECIATION>                                  53,019
<TOTAL-ASSETS>                                 455,410
<CURRENT-LIABILITIES>                           47,783
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           307
<OTHER-SE>                                     334,788
<TOTAL-LIABILITY-AND-EQUITY>                   455,410
<SALES>                                         52,150
<TOTAL-REVENUES>                                52,150
<CGS>                                           13,841
<TOTAL-COSTS>                                   28,724
<OTHER-EXPENSES>                                14,830
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 811
<INCOME-PRETAX>                                (6,447)
<INCOME-TAX>                                     1,435
<INCOME-CONTINUING>                            (7,882)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (7,882)
<EPS-PRIMARY>                                   (0.26)
<EPS-DILUTED>                                        0
        

</TABLE>
## SUPREME COURT OF THE STATE OF NEW YORK 

## Appellate Division, Fourth Judicial Department

1248 KA 12-01721 PRESENT: SMITH, J.P., FAHEY, CARNI, VALENTINO, AND WHALEN, JJ.

THE PEOPLE OF THE STATE OF NEW YORK, RESPONDENT,

V MEMORANDUM AND ORDER

JOHN SMITH, DEFENDANT-APPELLANT.

JAMES S. KERNAN, PUBLIC DEFENDER, LYONS (RICHARD W. YOUNGMAN OF COUNSEL), FOR DEFENDANT-APPELLANT.

JOHN SMITH, DEFENDANT-APPELLANT PRO SE.

RICHARD M. HEALY, DISTRICT ATTORNEY, LYONS (JACQUELINE MCCORMICK OF COUNSEL), FOR RESPONDENT.

Appeal from a judgment of the Wayne County Court (Dennis M. Kehoe, J.), rendered June 7, 2011. The judgment convicted defendant, upon his plea of guilty, of burglary in the first degree.

It is hereby ORDERED that the case is held, the decision is reserved and the matter is remitted to Wayne County Court for further proceedings in accordance with the following Memorandum: On appeal from a judgment convicting him, upon his plea of guilty, of burglary in the first degree (Penal Law § 140.30 [2]), defendant contends that County Court erred in failing to adjudicate him a youthful offender. We note at the outset that the People do not dispute defendant’s assertion that he is a “youth . . . eligible to be found a youthful offender” (CPL 720.10 [2]). “Upon conviction of an eligible youth, the court must order a [presentence] investigation of the defendant. After receipt of a written report of the investigation and at the time of pronouncing sentence the court must determine whether or not the eligible youth is a youthful offender” (CPL 720.20 [1]; see People v Rudolph , 21 NY3d 497, 503). Here, despite defendant’s application during the plea colloquy to be found an eligible youth, the court failed to address the issue of defendant’s eligibility during the sentencing proceeding. Furthermore, “we cannot deem the court’s failure to rule on the . . . [application] as a denial thereof” ( People v Spratley , 96 AD3d 1420, 1421, following remittal 103 AD3d 1211, lv denied 21 NY3d 1020; see People v Ingram , 18 NY3d 948, 949; People v Chattley , 89 AD3d 1557, 1558). We therefore hold the case, reserve decision, and remit the matter to County Court to make and state for the record “a determination of whether defendant is a-2- 1248 KA 12-01721

youthful offender” ( Rudolph , 21 NY3d at 503).

Entered: December 27, 2013 Frances E. Cafarell Clerk of the Court